ReportCancer

Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma

See allHide authors and affiliations

Science Translational Medicine  31 Jan 2018:
Vol. 10, Issue 426, eaan8723
DOI: 10.1126/scitranslmed.aan8723
PDF Container

Navigate This Article